MAPT and Alzheimer disease: A primary rat cortical neuron assay seeded with AD brain tissues for 14 days before the assessment of tau inclusions through immunostaining and imaging was applied to the screening of the Prestwick library, and a large number of inhibitors were identified, including four dopamine D2 receptor antagonists (Crowe et al., 2020).